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According to the American Cancer Society, there will be an estimat-
ed 12,710 new cases of cervical cancer with 4290 deaths in the US in
2011 (American Cancer Society). Even though the incidence and mor-
tality of cervical cancer has decreased in the US, there are still many pa-
tients, particularly fromminority groups, who continue to present with
advanced stages of the disease. The lifetime probability of developing
invasive cervical cancer is 1/145women,with themost common routes
of spread being local invasion of surrounding organs and through lym-
phatic channels (Monk and Tewari, 2007). Distant sites account for 27%
of metastasis, however there are only 5 previously reported cases of or-
bital metastases (Monk and Tewari, 2007; Gosslee et al., 2009; Park et
al., 2005; McCulley et al., 2002; Lee et al., 1997; Hertzanu et al., 1987).
Case report
A 59-year-old woman was evaluated for several months of foul-
smelling vaginal discharge followed by symptoms of pelvic discomfort
and difﬁculty voiding. She hadnot received a routine gynecologic exam-
ination inmore than 10 years. A computed tomography (CT) scan of the
pelvis and an exam under anesthesia (EUA) with tissue biopsies of the
cervix and a paravaginal mass was performed. The CT scan revealed a☆ Accepted andpresented as poster presentation at the 77th AnnualMeeting of the Cen-
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cervix without extension any further than the anterior vagina and im-
mediately adjacent tissue [Fig. 1]. Therewas no evidence of hydroureter
or para-aortic lymphadenopathy. A chest X-ray showed atelectasis,
however no masses were present. Histology showed poorly differenti-
ated squamous cell carcinoma. She was subsequently diagnosed with
stage IIIA carcinoma of the cervix given periurethral and vaginal in-
volvement. She was treated with concurrent external beam pelvic and
groin radiation therapy and weekly Cisplatin, followed by brachythera-
py. An EUA was performed during urethral interstitial implant place-
ment and the cervical mass had resolved with radiation changes at
the cervix. At her 3-month follow-up visit in clinic, she refused a pap
test and pelvic exam due to fear of discomfort.
Five months after initial presentation she was evaluated for a syn-
copal episode and fall. Work-up including head CT scan did not reveal
any abnormalities. One month later, she presented with headaches,
left eye proptosis, and epiphora with preserved vision. CT scan of the
orbits revealed a fusiform enlargement of the left lateral rectusmuscle
with a ﬂuid dense core and enhancing rim concerning for retrobulbar
abscess versus neoplastic process. This abnormality was not reported
on CT of the head including imaging of the orbits that was performed
1 month earlier. After excluding an infectious process, the patient was
started on corticosteroids and was scheduled to return for outpatient
ophthalmologic follow-up. Magnetic resonance imaging performed
2 weeks later showed an interval enlargement of the left retrobulbar
orbital mass. She underwent surgical biopsy and pathology was posi-
tive for squamous cell carcinoma consistent with metastasis from
cervical cancer [Fig. 2]. During this evaluation, the patient was offered
HIV screening twice but she declined the test.
She subsequently began radiation therapy to her left orbit. Despite
treatment, the orbitalmass nearly doubled in size over the nextmonth
[Fig. 3]. She was hospitalized again due to poor pain control and in-
tractable nausea and vomiting. Follow-up positron emission tomogra-
phy CT scans of the body also revealed interval development of widely
metastatic disease involving lung, liver, adrenals, bone, and scalp.
Despite palliative radiation therapy her clinical status continued to de-
teriorate and she was eventually sent home on hospice care. She died
10 months after the initial diagnosis of cervical cancer and 4 months
after the diagnosis of orbital metastasis.
Comment
There are only ﬁve cases of cervical cancer metastatic to the orbit
that have been reported in the literature (Gosslee et al., 2009; Park et
Fig. 1. CT scan with pelvic lesion causing urethral obstruction due to mass effect.
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Symptoms at the time of diagnosis included orbital pain, proptosis, lid
swelling, and diplopia with variable effects on visual acuity (Gosslee
et al., 2009; Park et al., 2005; McCulley et al., 2002; Lee et al., 1997;
Hertzanu et al., 1987). Stage at initial diagnosis of cervical carcinoma
ranged from FIGO IB1 to IV, though upon presentation with orbital me-
tastasis all but one case had concurrent distant metastases (Gosslee
et al., 2009; Park et al., 2005; McCulley et al., 2002; Lee et al., 1997;
Hertzanu et al., 1987). Time from primary diagnosis to orbital metasta-
siswas highly variable, ranging from4months to 10 years (Gosslee et al.,
2009; Park et al., 2005;McCulley et al., 2002; Lee et al., 1997;Hertzanu et
al., 1987). Histologywas also variable, including3 squamous cell carcino-
mas, one adenocarcinoma, and one undifferentiated carcinoma whoseFig. 2. Metastatic moderately differentiated squamous cell carcinoma with tumor cells show
magniﬁcation×100 and ×400).cervical origin was conﬁrmed by HPV PCR of the tissue biopsy (Gosslee
et al., 2009; Park et al., 2005; McCulley et al., 2002; Lee et al., 1997;
Hertzanu et al., 1987). Treatment of orbital metastases is usually pallia-
tive and consists of radiation therapy. Surgical excision and chemother-
apy may also be considered, but their beneﬁt has not been proven. All
patients had poor outcomes despite attempts of treatment with chemo-
therapy, radiation and/or surgery,with death ranging from3–10 months
after diagnosis of orbital metastasis (Gosslee et al., 2009; Park et al.,
2005; McCulley et al., 2002; Lee et al., 1997; Hertzanu et al., 1987).
As mentioned previously, cervical cancer metastasis occurs through
local invasion of surrounding tissue and through lymphatic dissemina-
tion. Hematogenous dissemination, although uncommon, is most likely
to involve the liver, bones or lungs (Monk and Tewari, 2007).ing marked pleomorphism, hyperchromasia and necrosis (hematoxylin-eosin, original
Fig. 3. Coronal view of CT scans showing interval enlargement in retrobulbar mass noted 1 month after initial presentation, despite palliative radiation therapy.
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matogenous dissemination to the orbit. Previous discussion of cervical
cancer metastatic to the central nervous system (CNS) suggests migra-
tion via the venous plexus of Batson and the inner vertebral plexus
(Tangjitgamol et al., 2004). The orbit can be considered an extension
of the same route, as the venous drainage of the eye communicates
with the dural venous sinuses of the CNS via the cavernous sinus and
ophthalmic veins. We hypothesize that hematogenous metastases to
the eye and orbit are more rare than brain metastases because the
ophthalmic veins are signiﬁcantly smaller caliber vessels than the CNS
venous sinuses and are also much further away from the venous drain-
age of the spine.
Due to the paucity of case reports on cervical cancer metastatic to
the orbit we are unable to identify any trend of histology, stage, treat-
ment or survival. If we consider the orbit an extension of the CNS,
there is more data available to comment on these features. Histolog-
ically, CNS metastases are seen more frequently with neuroendocrine
and poorly differentiated cervical carcinoma (Weed et al., 2003;
Chura et al., 2007). The histology in the presented case is poorly dif-
ferentiated squamous cell carcinoma, consistent with these observa-
tions. One of the more recent case series of brain metastases from
cervical cancer reported 9 patients with stage IIB or lower and 3 pa-
tients with stage IIIA or higher (Chura et al., 2007). The signiﬁcance
of this data is debatable since there is a higher incidence of lower
stages of cervical cancer due to early detection. Time from initial diag-
nosis to CNS metastasis ranged from 1 month to 8 years and treatment
options included steroids alone, radiation with steroids, surgery fol-
lowed by radiation or radiation followed by chemotherapy (Chura
et al., 2007). The study concluded that radiation therapy improved neu-
rological symptoms, but additional chemotherapy increased survival
signiﬁcantly (Chura et al., 2007). The distribution of histology, timeto diagnosis of metastasis, treatment and survival of these cases is
similar to the 6 reviewed cases of orbital metastasis, and therefore it
maybeworth applying thedata collected on improved survival to future
cases of orbital metastasis.
Even though CT scans of the abdomen and chest are not part of the
clinical staging evaluation of cervical cancer, this imaging is impera-
tive to exclude extra-pelvic disease. During our patient's initial evalu-
ation, there was a “probably enlarged”mediastinal lymph node noted
on CT chest that may have represented undiagnosed metastatic dis-
ease. Given that there is a signiﬁcant rate of recurrence, it is important
to continue short interval follow-up of cervical cancer patients in an
effort to promote early detection of recurrence or persistent disease.
Patients that present with speciﬁc new-onset symptoms should be
evaluated early and distant metastases should always be on the differ-
ential. Treatment options for metastatic disease may vary. Treatment
of orbital metastases in particular is usually palliative and consists of
radiation therapy with or without steroids and chemotherapy. Surgical
excision may also be considered, however the ﬁnding of orbital metas-
tasis in and of itself is an ominous sign.
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